Educational resources

Guidelines in Practice has developed a range of educational resources—including animations, formulary decision guides, implementation checklists, supplements, and webinars—to support you with your learning and implementation of best practice. Items may contain pharmaceutical promotional information.

Takeda webinar index 2019

Real-world evidence in the management of type 2 diabetes: switching from other DPP‑4 inhibitors to alogliptin (Vipidia®)

Commissioned by Takeda UK Ltd

This promotional educational webinar has been organised and funded by Takeda UK Ltd. See bottom of page for full disclaimer.

5-minute video_Chronic respiratory conditions and COVID-19-v2

NICE guidance on respiratory conditions and COVID-19: 5-minute video

By Dr Kevin Gruffydd-Jones

Dr Kevin Gruffydd-Jones highlights important things you need to know about managing respiratory conditions in a COVID-19 context

Coronavirus visualisation dark

Death certification in COVID-19: 5-minute video

By

Dr Toni Hazell highlights important things you need to know about changes to death certification processes during the COVID-19 outbreak

Alan Begg PAD video

Secondary event prevention and risk stratification in patients with symptomatic peripheral arterial disease (PAD)

Commissioned by Bayer Plc

Information intended for healthcare professionals only. The development of this Guidelines in Practice video has been commissioned by Bayer plc. Please see the bottom of the page for full disclaimer.

Matt Fay CAD video

Secondary event prevention and risk stratification in patients with stable coronary artery disease (CAD)

Commissioned by Bayer Plc

Information intended for healthcare professionals only. The development of this Guidelines in Practice video has been commissioned by Bayer plc. Please see the bottom of the page for full disclaimer.

PEI checklist

Implementing the clinical guideline on pancreatic exocrine insufficiency in diabetes

Supported by an educational grant from Mylan

Supported by an arm’s-length educational grant from Mylan.

Actinic keratosis checklist

Implementing the Primary Care Dermatology Society guideline and primary care treatment pathway for actinic (solar) keratosis

Supported by an educational grant from Almirall Ltd

Information intended for healthcare professionals only. Guidelines in Practice approached Almirall Ltd for an educational grant to support the production of an implementation checklist. Please see the bottom of the page for full disclaimer.

Amgevita FDG

Amgevita® ▼ (adalimumab biosimilar)

Commissioned by Amgen Ltd

This formulary discussion guide was developed from content provided by Amgen Ltd in a format developed by Guidelines in Practice.

Takeda logo

Case study on Type 2 diabetes management: implementation of a DPP-4 inhibitor switch strategy across a primary care network

Commissioned by Takeda UK Ltd

This advertorial has been commissioned and developed by Takeda UK Ltd. 

Index picture

Respimat® Soft Mist™ reusable inhaler: patient benefits and environmental impact

Commissioned by Boehringer Ingelheim Limited

This animation has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines in Practice. Boehringer Ingelheim Ltd suggested the topic and the presenter, and carried out full medical approval on all materials to ensure compliance with regulations. The sponsorship fee included an honorarium for the ...

Screen Shot 2020-02-25 at 15.20.11

Fencino® (fentanyl transdermal patch): clinical and practical considerations

Commissioned by Ethypharm UK Ltd

This animation has been commissioned and funded by Ethypharm UK Ltd and developed in partnership with Guidelines in Practice. Ethypharm UK Ltd suggested the topic and the presenter, and carried out full medical approval on all materials to ensure compliance with regulations. The sponsorship fee included an honorarium for the ...

Cost benefits eczema

Cost-benefit of prescribing emollients for eczema patients

Commissioned by Johnson & Johnson Limited

The content of this infographic has been developed by Johnson & Johnson Ltd.